Fact CheckerSign in

NCT07306728Not yet recruiting

Effect of Femoral Region Ice Bag Application on Patients' Clinical Outcomes Post-Percutaneous Coronary Intervention

Effect of Femoral Region Ice Bag Application on Patients' Clinical Outcomes

Source: ClinicalTrials.gov · Last updated 29 Dec 2025

Brief summary (registry, in English)

Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide, necessitating advancements in diagnostic techniques (Parulkar et al., 2025). According to the British Heart Foundation, over 250 million individuals worldwide are living with CAD, making it the most commonly diagnosed heart condition globally. In 2021, CAD was responsible for approximately 9 million deaths, accounting for about one in every seven deaths globally

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
14 Dec 2025
Start date
20 Dec 2025
Primary completion date
30 Mar 2026
Lead sponsor
Mansoura University
NCT number
NCT07306728

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 20 Dec 2025 to the primary completion date, 30 Mar 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • 1\. Patients with active infections 2. Patient with double femoral sheath region. 3. Patients with bleeding scar tissue from burns, wounds or hematoma in the femoral artery area before sheath removal.
    • 4\. Patients with known peripheral vascular disease affecting the femoral artery.
    • 5\. Allergy or contraindication to cold application. 6. Active bleeding at the access site. 7. Patients receiving anti-coagulation therapy beyond the standard post-PCI protocol.

Who the study is looking for

  • \- 1. Adult patients (aged 18 years and above) who have undergone elective PCI via femoral artery access.
  • 2\. Patients who are conscious, oriented, and able to report pain level. 3. Hemodynamically stable post-procedure.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.